Evolent Health Divests Primary Care Business to Privia

An announcement from Evolent Health ( (EVH) ) is now available.

On September 23, 2025, Evolent Health announced the strategic divestiture of its value-based primary care business, Evolent Care Partners, to Privia Health Group for up to $113 million. This move allows Evolent to focus on its core specialty business, reduce leverage, and improve cash flow by more than $7 million annually. The transaction is expected to close in the fourth quarter of 2025, and the proceeds will be used to repay senior term debt. Evolent also reaffirmed its revenue and adjusted EBITDA guidance for the third quarter and full year 2025, excluding the impact of this transaction.

The most recent analyst rating on (EVH) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Evolent Health stock, see the EVH Stock Forecast page.

Spark’s Take on EVH Stock

According to Spark, TipRanks’ AI Analyst, EVH is a Neutral.

Evolent Health’s overall stock score reflects a challenging financial performance with declining revenues and persistent losses. However, the company shows promise in its earnings call with strong adjusted EBITDA and strategic partnerships, which provide a positive outlook. Technical analysis and valuation metrics are less favorable, indicating bearish momentum and unattractive valuation.

To see Spark’s full report on EVH stock, click here.

More about Evolent Health

Evolent Health, Inc. specializes in improving health outcomes for individuals with complex conditions by providing solutions that simplify and make healthcare more affordable. The company serves a national base of leading payers and providers and is recognized as a top workplace in the healthcare industry.

Average Trading Volume: 3,082,294

Technical Sentiment Signal: Sell

Current Market Cap: $1.01B

For detailed information about EVH stock, go to TipRanks’ Stock Analysis page.